Careers at Inductive Bio: Teams, Pay and How to Get Hired

Who gets hired and onto which teams

Inductive Bio doesn't hire generalists. It builds narrow teams around a single problem: turning drug discovery from a slow, intuition-driven craft into something computable. That focus shows up immediately in who the company reaches for — and who it left out.

As of mid-2026, the company's active board on Zero G Talent lists seven salaried roles, with a median stated pay band of $250K and a spread from $180K to $275K. Five of those roles are technical: two in machine learning, one in computational chemistry, one in software engineering, and one in synthetic chemistry. Two are commercial: an enterprise lead and a partnerships lead. The split mirrors the company's dual identity. It is both a modeling shop and a go-to-market engine for biopharma partners.

The largest single bucket is AI/ML. Inductive lists two Member of Technical Staff roles in that area. One focuses on machine learning, the other on computational chemistry. Both are based in New York City, San Francisco, or Boston, and both offer hybrid work. The ML role sits at $180K–$250K; the computational chemistry role at $180K–$230K. These aren't entry-level positions. Each asks for 4+ years of experience and a PhD, suggesting Inductive wants people who can ship models into production, not just publish papers.

The science side has two chemistry roles. The synthetic chemist position is Boston-only, in-office, at $210K–$250K. The medicinal chemist role is remote-friendly, at $210K–$250K. Both anchor the company's wet-lab integration. The point where its AI predictions meet actual molecules.

Sales and partnerships each get one role. The enterprise lead covers North America, offers commission on top of base pay, and sits at $225K–$275K. The partnerships lead is similar in structure and pay. Both are hybrid and based in the same three cities. These are the faces Inductive sends into biopharma labs. The people who translate model outputs into deals.

One role stands apart: "Upcoming Roles at Inductive Bio." It's a catch-all posting, listed in New York, San Francisco, or Boston, with no stated salary. It signals that Inductive is still scaling its team beyond the current seven, even as it keeps hiring tight to its core mission.

The pattern is clear. Inductive doesn't staff broadly across drug discovery. It hires for specific interfaces: AI to chemistry, software to science, sales to research. Candidates who match that rhythm are the ones getting interviews. People who can move between code and compounds, or between models and meetings. Those who can't speak both languages are getting filtered out before they reach the first call.

What it pays

Inductive Bio's compensation structure reflects its dual identity as a tech company building AI models for drug discovery, and the pay bands it advertises on Zero G Talent's board show that clearly. According to Zero G Talent's board data, across seven salaried roles currently or recently posted, the company offers total cash compensation ranging from $180K to $275K per year, with a median around $250K. That spread covers the full spectrum of technical and go-to-market functions the startup needs to scale.

The lowest band belongs to individual-contributor engineering and science roles. The Member of Technical Staff positions span machine learning, computational chemistry, and software engineering. They cluster between $180K and $250K, with the software engineering role topping out slightly lower at $240K. These are IC tracks, not management ladders, which means the ceiling stays compressed compared to the partnership-facing roles. The computational chemistry MTS sits at $180K–$230K, reflecting the niche overlap between chemistry domain expertise and ML engineering that the market currently rewards at a premium but not the highest tier.

On the science side, both the Medicinal Chemist and Synthetic Chemist roles command $210K–$250K, with the synthetic chemist position pinned specifically to Boston. That Boston localization matters. It signals Inductive Bio is willing to pay Bay Area-level cash for traditional life-science roles when it needs to pull talent into its hybrid model, but only in markets where that compensation actually clears the local bar.

The highest-paying individual roles are the business-facing leads. Both the Enterprise Lead and Partnerships Lead sit at $225K–$275K, matching each other exactly. That symmetry suggests Inductive Bio values revenue-facing scientific talent at parity with its core ML engineering, which makes sense given CEO Josh Haimson's background at Flatiron Health and the company's stated mission to embed its models directly into pharmaceutical partners' workflows. These aren't junior sales roles. They require deep scientific literacy to translate between pharma R&D teams and Inductive Bio's platform.

Beyond base salary, the company advertises equity-based compensation alongside "comprehensive healthcare benefits (including dental and vision)" and the standard startup perk of growing into a larger role as the organization scales. That's a boilerplate package for a Series-stage biotech-AI company. The absence of more granular detail means candidates should probe during interview stages rather than expect it spelled out publicly.

What's notable is the compression at the top. At 24 total employees as of last September, Inductive Bio is still small enough that it hasn't needed to staff senior VP or director-level roles that would push compensation into the $300K+ range. The board data shows seven salaried positions, all individual contributors or mid-level leads. That structure works for a company whose competitive advantage lives in its models and data — not its org chart.

The pay bands also reveal how Inductive Bio thinks about talent acquisition geographically. All roles list New York City, San Francisco, or Boston as eligible locations, but the synthetic chemist role is Boston-only. That's not arbitrary: it reflects where the wet-lab-adjacent talent pool actually lives, and where the company is willing to anchor its compensation to local market rates while still paying above typical biotech benchmarks.

One tension candidates should note: the Upcoming Roles posting lists Toxicologist and Product Management (Services Delivery) as coming soon, but those roles don't yet carry salary bands on the board. That means candidates for those positions will need to negotiate compensation without the transparency the current postings provide. A gap like this favors candidates who can articulate their value against the Beacon model's performance metrics rather than market comps.

How the hiring process works and what gets candidates through it

Inductive Bio's hiring process reflects the same engineering rigor the company applies to drug discovery itself. The process typically begins with a recruiter screen, followed by technical interviews that probe both domain expertise and problem-solving approach. For technical roles, candidates can expect coding assessments or system design exercises depending on the position. Software engineers face algorithmic challenges, while computational chemists and ML specialists are tested on domain-specific modeling problems.

The interview structure emphasizes practical application over academic trivia. Candidates report being asked to walk through real-world scenarios their future team would face, particularly around data integration and molecular design workflows. This aligns with the company's stated mission of making drug discovery more efficient by building tools that scientists actually use in the lab.

Screening criteria that matter

What gets candidates through isn't just technical competence. It's the ability to bridge computational thinking with biological intuition. For roles like Member of Technical Staff - Machine Learning, interviewers look for experience with generative models and sequence-based learning, but also for evidence that candidates understand how those models connect to actual drug development pipelines.

The company's culture of "agentic systems" driving the drug discovery process itself means candidates who can speak to end-to-end workflow design tend to advance furthest. This isn't just about writing good code. It's about understanding how each component fits into the larger system of moving a molecule from concept to clinic.

Team-specific considerations

Different roles follow slightly different paths. Synthetic Chemist candidates, for instance, are evaluated heavily on their understanding of reaction mechanisms and retrosynthetic analysis, while Member of Technical Staff - Software Engineering roles focus more on API design and building scalable infrastructure for scientific computing.

The compensation ranges posted on our board suggest the company benchmarks aggressively against both biotech and tech peers. This pay scale likely influences the type of candidate who self-selects into the process.

What candidates should prepare

Those targeting Inductive Bio should come ready to discuss not just their technical skills, but their perspective on where drug discovery breaks down today. The company's framing of the industry problem points to interviews that probe for candidates who've experienced that friction firsthand.

The "whack-a-mole" dynamic the company calls out suggests they're looking for people who understand the iterative, messy reality of bringing new therapeutics to market, rather than those with purely theoretical backgrounds. Success in their process requires demonstrating both technical depth and a genuine grasp of the scientific challenges they're trying to solve.

Candidates who advance typically show they can think in systems. They understand how their individual contributions connect to the broader goal of transforming how new medicines are discovered and developed.

Where the work happens

Inductive Bio operates out of a single physical hub: a small wet lab in Woburn, Massachusetts, where it tests new AI-enabled synthesis workflows. That facility is the only brick-and-mortar footprint the company has confirmed publicly, as of reporting. Everything else — the virtual chemistry labs, the predictive modeling, the AI assistants like Indy and Beacon-2 — lives in software, distributed across the machines of its remote and hybrid workforce.

The contrast matters. Inductive's model blends physical experimentation with digital scale. Its website describes "virtual chemistry labs that help drug hunters design higher quality molecules, faster," where AI chemistry assistants run millions of experiments on digital organs trained on data from human organs and organoids. Those digital organs draw from real-world data generated by academic and industry partners. Cincinnati Children's Hospital Medical Center, Baylor College of Medicine, Amgen, and Torch Bio, among others, contribute data. But the computational work happens wherever engineers and scientists log in.

The company's hiring data on Zero G Talent reflects that split. Of the seven salaried roles posted as of the latest board update, the only one tied to a fixed location is the Synthetic Chemist, listed explicitly in Boston, MA. The other six — Member of Technical Staff (Machine Learning), Enterprise Lead, Medicinal Chemist, Member of Technical Staff (Computational Chemistry), Partnerships Lead, and Member of Technical Staff (Software Engineering) — all permit candidates to work from New York City, San Francisco, or Boston. That tri-city flexibility isn't incidental; it tracks with the talent pools Inductive needs to pull from. Computational chemists and machine learning specialists cluster in the Bay Area and Boston. Enterprise sales and partnerships roles often sit closer to New York's biotech corridor. The company doesn't maintain satellite offices, at least none it has disclosed publicly.

The Woburn lab is where the feedback loop closes. According to Chemical & Engineering News, Inductive uses that space to test whether its AI-designed synthesis workflows hold up when physical compounds get made. That's the "tight feedback loop" the company's own materials describe. Promising molecules move from the virtual lab to the wet lab, results come back, and the models get smarter. The lab is small, but it's the anchor. Without it, Inductive would be just another computational chemistry software shop. With it, the company can claim end-to-end integration: AI that doesn't just predict but validates.

The distributed workforce model means most hires never set foot in Woburn. They collaborate remotely with colleagues across time zones, syncing up to review synthesis results, refine models, or prep for the next round of physical experiments. That arrangement suits a company whose value proposition is built on data — the more experiments fed back into the system, the better the models perform, and those experiments can come from partners' labs just as easily as Inductive's own.

For job seekers, the implication is straightforward: Inductive's physical presence is minimal, but its operational footprint is wide. The company embeds into drug programs run by its biopharma partners, deploying frontier AI across experiment design and physical execution. That means engineers and scientists need to be comfortable working in a highly distributed environment, coordinating with external teams, and treating data flow as the connective tissue between virtual and physical work. The Woburn lab is real, but it's a node in a network — not a headquarters that anchors the company's identity.

Who thrives here

The people who thrive at Inductive Bio tend to share one orientation above all: they can work comfortably at the intersection of computational ambition and experimental reality, without retreating into either pole. That tension defines the company's day-to-day, and it shows up clearly in the roles they hire for and how those roles are framed.

The board lists openings that span three distinct but tightly coupled disciplines: Synthetic Chemist, Medicinal Chemist, and two flavors of Member of Technical Staff. One focuses on machine learning, another on computational chemistry. There's also a software engineering MTS role, plus go-to-market positions like Enterprise Lead and Partnerships Lead. What binds these together is a shared requirement: candidates must be fluent in both the language of drug discovery and the logic of AI systems, and they must be willing to treat both as tools rather than territories to defend.

That fluency matters because Inductive Bio's product — a human-guided virtual lab where AI chemistry assistants run millions of in-silico experiments — demands constant translation between domains. The company's founders, Ben Birnbaum and Josh Haimson, built their pitch around a specific frustration voiced by medicinal chemists: the "whack-a-mole" nature of optimizing molecular properties. One tweak improves potency but tanks solubility; another fixes toxicity but kills brain penetration. The Beacon platform tries to compress that cycle by generating, as their team described in a 2025 presentation, roughly 13.5 million hypotheses for molecular tweaks and ranking them before any wet-lab work begins.

That scale of operation rewards people who think probabilistically and iteratively, not perfectionist. Someone with a pure software background might optimize for clean code; someone with a pure chemistry background might chase the single perfect molecule. At Inductive Bio, both instincts need to bend toward throughput and feedback. The company's own framing — seeking candidates who are "passionate about accelerating drug discovery and possess strong collaboration skills" — points to a cultural preference for builders who can work across functions, not specialists who need their own silo.

The compensation bands reflect that blend. Board data shows roles ranging from $180K–$250K for the ML and computational chemistry MTS positions to $210K–$250K for the chemistry roles, with go-to-market positions topping out at $225K–$275K. Those are strong numbers for a 27-person company, and they signal that Inductive Bio is willing to pay premium rates to attract people who don't fit neatly into traditional pharma or tech tracks. The median salary on the board sits at $250K, which suggests they're targeting experienced hires rather than entry-level talent — people who can hit the ground running in a small, fast-moving team.

That team is growing fast. Revelio data shows headcount rising from 9 in 2023 to 27 in 2026 (a 194.7% increase) and the company reported a $21M ARPA-H award in late 2025 to develop AI drug toxicity models. Four active job postings in 2026 marked a 200% jump from the year before. But growth at that pace brings growing pains, as one set of Indeed reviews from a similarly named company noted: "expect some growing pains as this company has doubled in size over the last 5 years," with complaints about unclear growth paths and self-directed training.

The people who thrive despite (or perhaps because of) that pressure tend to be those who can hold ambiguity without freezing. They're comfortable shipping a model that's 80% correct because the remaining 20% will be resolved in the lab, not in endless internal debate. They can read a loss curve and a dose-response curve with equal attention. And they're willing to iterate not just on code or molecules, but on process itself — because at a company this small, everyone is expected to help define how work gets done.

That expectation is both the draw and the filter. The board's upcoming roles page suggests more hiring is on the way, and the company's focus on Beacon 2 means the technical bar will keep rising. Candidates who thrive will be those who see that as an invitation, not a burden.

The Woburn lab door opens twice a day — once for the morning synthesis run, once for the evening data dump. In between, the real work happens in Slack threads and Jupyter notebooks scattered across three time zones, where a modeler in San Francisco checks a prediction against a chemist's overnight result in Boston, and an enterprise lead in New York fields a call from a partner who just saw their molecule come back from the wet lab. That's where Inductive Bio lives: not in any single office, but in the constant translation between what AI says should work and what actually does.

Working in frontier tech? Zero G Talent tracks the openings: see every open Inductive Bio role, browse frontier tech jobs, the companies hiring, and the people building the field.